• Thurs news: GSK inks 2nd neuro pact in weeks. Teva episodic migraine trial. FDA clears AZ’s Imfinzi for aggressive lung cancer. Novartis fails to block generic Entresto. Nuvig gets immune drug funding. See more on our front page

VaxInnate

Anonymous board for VaxInnate
Replies
2
Views
3K
anonymous
Replies
1
Views
2K
anonymous
Replies
3
Views
4K
anonymous
Replies
11
Views
5K
anonymous
Replies
0
Views
2K
Anonymous
Replies
1
Views
3K
Anonymous
Replies
10
Views
4K
Anonymous
Replies
1
Views
4K
Anonymous
Replies
0
Views
4K
Anonymous